Advertisement

IgA-Associated Diseases

  • Jiri Mestecky
  • Lennart Hammarström

In many species, including humans, IgA is produced in quantities that far exceed the combined synthesis of all other immunoglobulin (Ig) isotypes (Conley and Delacrox, 1987; Mestecky et al., 2005). It is estimated that in humans, <66 mg/ kg body weight (i.e., 4–5 g in a 70-kg adult) is produced daily, in contrast with ~25 mg/kg/day for IgG and much less for other isotypes. IgA displays diverse metabolic properties due to its heterogeneity of molecular forms (two subclasses, both of which can form monomers and polymers) and two distinct major sites of production (bone marrow and mucosal tissues) (Mestecky et al., 2005).

Keywords

Multiple Myeloma Mesangial Cell Common Variable Immunodeficiency IgAN Patient Asialoglycoprotein Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, A. C., Bailey, E.M., Brenchley, P. E., Buck, K. S., Barratt, J., and Feehally, J. (2001). Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 60:969–973.PubMedCrossRefGoogle Scholar
  2. Allen, A. C., Willis, F. R., Beattie, T. J., and Feehally, J. (1998). Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol. Dial. Transplant. 13:930–934.PubMedCrossRefGoogle Scholar
  3. Alley, C. D., Nash, G. S., and MacDermott, R. P. (1982). Marked in vitro spontaneous secretion of IgA by human rib bone marrow mononuclear cells. J. Immunol. 128:2604–2608.PubMedGoogle Scholar
  4. Ambrus, M., Hernadi, E., and Bajtai, G. (1977). Prevalence of HLA-A1 and HLA-B8 antigens in selective IgA deficiency. Clin. Immunol. Immunopathol. 7:311–314.PubMedCrossRefGoogle Scholar
  5. Ammann, A. J., and Hong, R. (1971). Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine 50:223–236.PubMedCrossRefGoogle Scholar
  6. Asindi, A. A., Bell, E. J., Browning, M. J., and Stephenson, J. B. (1988). Vaccine-induced polioencephalomyelitis in Scotland. Scott. Med. J. 33:306–307.PubMedGoogle Scholar
  7. Bast, E. J., Van Camp, B., Boom, S. E., Jaspers, F. C., and Ballieux, R. E. (1981). Differentiation between benign and malignant monoclonal gammopathy by the presence of the J chain. Clin. Exp. Immunol. 44:375–382.PubMedGoogle Scholar
  8. Björkander, J., Hammarström, L., Smith, C. I., Buckley, R. H., Cunningham-Rundles, C., and Hanson, L. Å. (1987). Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J. Clin. Immunol. 7:8–15.PubMedCrossRefGoogle Scholar
  9. Borecki, I. B., McGue, M., Gerrard, J. W., Lebowitz, M. D., and Rao, D. C. (1994). Familial resemblance for immunoglobulin levels. Hum. Genet. 94:179–185.PubMedCrossRefGoogle Scholar
  10. Briere, F., Bridon, J. M., Chevet, D., Souillet, G., Bienvenu, F., Guret, C., Martinez-Valdez, H., and Banchereau, J. (1994). Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J. Clin. Invest. 94:97–104.PubMedCrossRefGoogle Scholar
  11. Brown, W. R. (2005). Liver and biliary tract. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 1373–1387.Google Scholar
  12. Burks, A. W., Sampson, H. A., and Buckley, R. H. (1986). Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N. Engl. J. Med. 314:560–564.PubMedGoogle Scholar
  13. Carneiro-Sampaio, M. M., Carbonare, S. B., Rozentraub, R. B., de Araujo, M. N., Riberiro, M. A., and Porto, M. H. (1989). Frequency of selective IgA deficiency among Brazilian blood donors and healthy pregnant women. Allergol. Immunopathol. 17:213–216.Google Scholar
  14. Castigli, E., Scott, S., Dedeoglu, F., Bryce, P., Jabara, H., Bhan, A. K., Mizoguchi, E., and Geha, R. S. (2004). Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 101:3903–3908.PubMedCrossRefGoogle Scholar
  15. Castigli, E., Wilson, S. A., Garibyan, L., Rachid, R., Bonilla, F., Schneider, L., and Geha, R. S. (2005 ). TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37:829–834.PubMedCrossRefGoogle Scholar
  16. Conley, M. E., and Cooper, M. D. (1981). Immature IgA B cells in IgA-deficient patients. N. Engl. J. Med. 305:495–497.PubMedGoogle Scholar
  17. Conley, M. E., and Delacroix, D. L. (1987). Intravascular and mucosal immunoglobulin A: Two separate but related systems of immune defense? Ann. Intern. Med. 106:892–899.PubMedGoogle Scholar
  18. Cripps, A. W., and Gleeson, M. (2005). Ontogeny of mucosal immunity and aging. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 305–321.Google Scholar
  19. Czerkinsky, C., Koopman, W. J., Jackson, S., Collins, J. E., Crago, S. S., Schrohenloher, R. E., Julian, B. A., Galla, J. H., and Mestecky, J. (1986). Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J. Clin. Invest. 77:1931–1938.PubMedCrossRefGoogle Scholar
  20. de la Concha, E. G., Fernandez-Arquero, M., Gual, L., Vigil, P., Martinez, A., Urcelay, E., Ferreira, A., Garcia-Rodriguez, M. C., and Fontan, G. (2002). MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 169:4637–4643.PubMedGoogle Scholar
  21. de Laat, P. C., Weemaes, C. M., Bakkeren, J. A., van den Brandt, F. C., van Lith, T. G., de Graaf, R., van Munster, P. J., and Stoelinga, G. B. (1991). Familial selective IgA deficiency with circulating anti-IgA antibodies: a distinct group of patients? Clin. Immunol. Immunopathol. 58:92–101.PubMedCrossRefGoogle Scholar
  22. Delacroix, D. L., Elkon, K. B., Geubel, A. P., Hodgson, H. F., Dive, C., and Vaerman, J. P. (1983). Changes in size, subclass, and metabolic properties in serum immunoglobulin A in liver diseases with high serum immunoglobulin A. J. Clin. Invest. 7l:358–367.CrossRefGoogle Scholar
  23. Delacroix, D. L., and Vaerman, J. P. (1983). Function of the human liver in IgA homeostasis in plasma. Ann. NY Acad. Sci. 409:383–401.PubMedCrossRefGoogle Scholar
  24. Dieli, F., Asherson, G. L., Sireci, G., Lio, D., Bonanno, C. T., and Salerno, A. (1995). IL-5 enhances in vitro and in vivo antigen-specific IgA production in MHC genetically determined low IL-5 responder mice. Cell. Immunol. 163:309–313.PubMedCrossRefGoogle Scholar
  25. Donadio, J. V., and Grande, J. P. (2002). IgA nephropathy. N. Engl. J. Med. 347:738–748.PubMedCrossRefGoogle Scholar
  26. Emancipator, S., Mestecky, J., and Lamm, M. E. (2005). IgA nephropathy and related diseases. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 1579–1600.Google Scholar
  27. Ezeoke, A. C. (1988). Selective IgA deficiency (SIgAD) in Eastern Nigeria. Afr. J. Med. Sci. 17:17–21.Google Scholar
  28. Farr, M., Kitas, G. D., Tunn, E. J., and Bacon, P. A. (1991). Immunodeficiencies associated with sulphasalazine therapy in inflammatory arthritis. Br. J. Rheumatol. 30:413–417.PubMedCrossRefGoogle Scholar
  29. Feng, L. (1992). Epidemiological study of selective IgA deficiency among 6 nationalities in China. Chin. Med. J. 72:88–90.Google Scholar
  30. Ferreira, A., Garcia Rodriguez, M. C., Lopez-Trascasa, M., Pascual Salcedo, D., and Fontan, G. (1988). Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with c-globulin. Clin. Immunol. Immunopathol. 47:199–207.PubMedCrossRefGoogle Scholar
  31. Finck, A., van der Meer, J. W. M., Schaffer, A. A., Pfannstiel, J., Fieschi, C., Plebani, A., Webster, A. D. B., Hammarström, L., and Grimbacher, B. (2006). Linkage of autosomal dominant common variable immunodeficiency to chromosome 4q. Eur. J. Hum. Genet. 14:867–875.PubMedCrossRefGoogle Scholar
  32. Friman, V., Hanson, L. A., Bridon, J. M., Tarkowski, A., Banchereau, J., and Briere, F. (1996). IL-10-driven immunoglobulin production by B lymphocytes from IgA-deficient individuals correlates to infection proneness. Clin. Exp. Immunol. 104:432–438.PubMedCrossRefGoogle Scholar
  33. Frommel, D., Moullec, J., Lambin, P., and Fine, J. M. (1973). Selective serum IgA deficiency. Frequency among 15, 200 French blood donors. Vox Sang. 25:513–518.PubMedCrossRefGoogle Scholar
  34. Galla, J. H., Spotswood, M. F., Harrison, L. A., and Mestecky, J. (1985). Urinary IgA in IgA nephropathy and Henoch-Schoenlein purpura. J. Clin. Immunol. 5:298–306.PubMedCrossRefGoogle Scholar
  35. Gardulf, A., and Hammarström, L. (1996). Subcutaneous administration of immunoglobulins. What are the advantages. Clin. Immunother. 6:108–116.Google Scholar
  36. Gardulf, A., Hammarström, L., and Smith, C. I. (1991). Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet 338:162–166.PubMedCrossRefGoogle Scholar
  37. Gual, L., Martinez, A., Fernandez-Arquero, M., Garcia-Rodriguez, M. C., Ferreira, A., Fontan, G., de la Concha, E. G., and Urcelay, E. (2004). Major histocompatibility complex haplotypes in Spanish immunoglobulin A deficiency patients: A comparative fine mapping microsatellite study. Tissue Antigens 64:671–677.PubMedCrossRefGoogle Scholar
  38. Gustafson, R., Gardulf, A., Granert, C., Hansen, S., and Hammarström, L. (1997). Prophylactic therapy for selective IgA deficiency. Lancet 350:865.PubMedCrossRefGoogle Scholar
  39. Haddad, E., Moura, I. C., Arcos-Fajardo, M., Macher, M. A., Baudouin, V., Alberti, C., Loirat, C., Monteiro, R. C., and Peuchmaur, M. (2003). Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: Association between CD71 expression and IgA deposits. J. Am. Soc. Nephrol. 14:327–337.PubMedCrossRefGoogle Scholar
  40. Halsey, N. A., Pinto, J., Espinosa-Rosales, F., Faure-Fontenla, M. A., da Silva, E., Khan, A. J., Webster, A. D., Minor, P., Dunn, G., Asturias, E., Hussain, H., Pallansch, M. A., Kew, O. M., Winkelstein, J., and Sutter, R. (2004). Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull. World Health Org. 82:3–8.PubMedGoogle Scholar
  41. Hammarström, L., de Lange, G. G., and Smith, C. (1987). IgA2 allotypes determined by restriction fragment length polymorphism in IgA deficiency. Re-expression of the silent A2m(2) allotype in the children of IgA-deficient patients. J. Immunogenet. 14:197–201.PubMedCrossRefGoogle Scholar
  42. Hammarström, L., Grubb, R., Jakobsen, B. K., Oxelius, V., Persson, U., and Smith, C. I. E. (1986). Concomitant deficiency of IgG4 and IgE in IgA deficient donors with high titres of anti-IgA. Monogr. Allergy 20:234–235.Google Scholar
  43. Hammarström, L., Grubb, R., and Smith, C. I. (1985a). Gm allotypes in IgA deficiency. J. Immunogenet. 12:125–130.PubMedCrossRefGoogle Scholar
  44. Hammarström, L., Lönnqvist, B., Ringdén, O., Smith, C.I., and Wiebe, T. (1985b). Transfer of IgA deficiency to a bone-marrow-grafted patient with aplastic anaemia. Lancet 1:778–781.PubMedCrossRefGoogle Scholar
  45. Hammarström, L., Persson, M. A., and Smith, C. I. (1983). Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA. Scand. J. Immunol. 18:509–513.PubMedCrossRefGoogle Scholar
  46. Hammarström, L., Persson, M. A., and Smith, C. I. (1985c). Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology 54:821–826.PubMedGoogle Scholar
  47. Hammarström, L., and Smith, C. I. (1983). HLA-A, B, C and DR antigens in immunoglobulin A deficiency. Tissue Antigens 21:75–79.PubMedCrossRefGoogle Scholar
  48. Hammarström, L., and Smith, C. I. E. (2007). Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs, H., Smith, C. I. E., and Puck, J. (eds.), Primary Immunodeficiency Diseases, a Molecular and Genetic Approach. Oxford University Press, pp. 313–325.Google Scholar
  49. Hammarström, V., Smith, C. I., and Hammarström, L. (1993). Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 341:1036.PubMedCrossRefGoogle Scholar
  50. He, B., Qiao, X., Klasse, P. J., Chiu, A., Chadburn, A., Knowles, D. M., Moore, J. P., and Cerutti, A. (2006). HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors. J. Immunol. 176:3931–3941.PubMedGoogle Scholar
  51. Heremans, J. F. (1974). Immunoglobulin A. In: Sela, M. (ed.), The Antigens. Academic Press, New York, pp. 365–522.Google Scholar
  52. Hiki, Y., Odani, H., Takahashi, M., Yasuda, Y., Nishimoto, A., Iwase, H., Shinzato, T., Kobayashi, Y., and Maeda, K. (2001). Mass spectrometry proves under O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 59:1077–1085.PubMedCrossRefGoogle Scholar
  53. Hobbs, J. R. (1968). Immune imbalance in dysgammaglobulinaemia type IV. Lancet 1:110–114.PubMedCrossRefGoogle Scholar
  54. Holt, P. D., Tandy, N. P., and Anstee, D. J. (1977). Screening of blood donors for IgA deficiency: A study of the donor population of south-west England. J. Clin. Pathol. 30:1007–1010.PubMedCrossRefGoogle Scholar
  55. Huntley, C. C., and Stephenson, R. L. (1968). IgA deficiency: family studies. NC Med. J. 29:325–331.Google Scholar
  56. Islam, K. B., Baskin, B., Nilsson, L., Hammarström, L., Sideras, P., and Smith, C. I. (1994). Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J. Immunol.152:1442–1452.PubMedGoogle Scholar
  57. Julian, B. A., and Novak, J. (2004). IgA nephropathy: An update. Curr. Opin. Nephrol. Hypertens. 13:171–179.PubMedCrossRefGoogle Scholar
  58. Julian, B. A., Tomana, M., Novak, J., and Mestecky, J. (1999). Progress in pathogenesis of IgA nephropathy. In: Grunfeld, J.-P., Bach, J. F., and Kreis, H. (eds.), Advances in Nephrology, Vol. 29, Mosby, St. Louis, MO, pp. 53–72.Google Scholar
  59. Kanoh, T., Mizumoto, T., Yasuda, N., Koya, M., Ohno, Y., Uchino, H., Yoshimura, K., Ohkubo, Y., and Yamaguchi, H. (1986). Selective IgA deficiency in Japanese blood donors: Frequency and statistical analysis. Vox Sang. 50:81–86.PubMedCrossRefGoogle Scholar
  60. Kilian, M., and Russell, M. W. (2005). Microbial evasion of IgA functions. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 291–303.Google Scholar
  61. Koistinen, J. (1975). Selective IgA deficiency in blood donors. Vox Sang. 29:192–202.PubMedCrossRefGoogle Scholar
  62. Koskinen, S., Tolo, H., Hirvonen, M., and Koistinen, J. (1994). Long-term persistence of selective IgA deficiency in healthy adults. J. Clin. Immunol. 14:116–119.PubMedCrossRefGoogle Scholar
  63. Kralovicova, J., Hammarström, L., Plebani, A., Webster, A. D., and Vorechovsky, I. (2003). Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170:2765–2775.PubMedGoogle Scholar
  64. Kramer, J., Kassai, T., Medgyesi, G. A., Tauszik, T., and Fust, G. (1988). Screening of IgA deficiency by ELISA: Population frequency in Hungary. Haematologia 21:233–238.PubMedGoogle Scholar
  65. Kubagawa, H., Bertoli, L. F., Barton, J. C., Koopman, W. J., Mestecky, J., and Cooper, M. D. (1987). Analysis of paraprotein transport into saliva by using anti-idiotype antibodies. J. Immunol. 138:435–439.PubMedGoogle Scholar
  66. Kurobane, I., Riches, P. G., Sheldon, J., Jones, S., and Hobbs, J. R. (1991). Incidental correction of severe IgA deficiency by displacement bone marrow transplantation. Bone Marrow Transplant. 7:494–495.PubMedGoogle Scholar
  67. Kutteh, W. H., Prince, S. J., and Mestecky, J. (1982a). Tissue origins of human polymeric and monomeric IgA. J. Immunol. 128:990–995.PubMedGoogle Scholar
  68. Kutteh, W. H., Prince, S. J., Phillips, J. O., Spenney, J. G., and Mestecky, J. (1982b). Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile. Gastroenterology 82:184–193.PubMedGoogle Scholar
  69. Lewkonia, R. M., Gairdner, D., and Doe, W. F. (1976). IgA deficiency in one of identical twins. Br. Med. J. 1:311–313.PubMedCrossRefGoogle Scholar
  70. Li, G. S., Zhang, H., Lv, J. C., Shen, Y., and Wang, H. Y. (2007). Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 71:448–453.PubMedCrossRefGoogle Scholar
  71. Lindberg, K., Samuelson, A., Rynnel-Dagöö, B., Smith, E., and Hammarström, L. (1993). Nasal administration of IgA to individuals with hypogammaglobulinemia. Scand. J. Infect. Dis. 25:395–397.PubMedCrossRefGoogle Scholar
  72. Lio, D., D’Anna, C., Gervasi, F., Cigna, D., Modica, M. A., Candore, G., and Caruso, C. (1995). In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction. Hum. Immunol. 44:170–174.PubMedCrossRefGoogle Scholar
  73. Litzman, J., Sevcikova, I., Stikarovska, D., Pikulova, Z., Pazdirkova, A., and Lokaj, J. (2000). IgA deficiency in Czech healthy individuals and selected patient groups. Int. Arch. Allergy Immunol. 123:177–180.PubMedCrossRefGoogle Scholar
  74. Lokhorst, H. M., Dekker, A. W., Baarlen, J. V., and Bast, E. J. E. G. (1990). J chain disease: An aggressive evolution of multiple myeloma. Am. J. Med. 88:417–420.PubMedCrossRefGoogle Scholar
  75. Mattu, T. S., Pleass, R. J., Willis, A. C., Kilian, M., Wormald, M. R., Lellouch, A. C., Rudd, P. M., Woof, J. M., and Dwek, R. A. (1998). The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J. Biol. Chem. 273:2260–2272.PubMedCrossRefGoogle Scholar
  76. Mellemkjaer, L., Hammarström, L., Andersen, V., Yuen, J., Heilmann, C., Barington, T., Björkander, J., and Olsen, J. H. (2002). Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: A combined Danish and Swedish study. Clin. Exp. Immunol. 130:495–500.PubMedCrossRefGoogle Scholar
  77. Mestecky, J., Jackson, S., Moldoveanu, Z., Nesbit, L. R., Kulhavy, R., Prince, S. J., Sabbaj, S., Mulligan, M. J., and Goepfert, P. A. (2004). Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. AIDS Res. Hum. Retroviruses 20:972–988.PubMedCrossRefGoogle Scholar
  78. Mestecky, J., Moldoveanu, Z., Julian, B. A., and Prchal, J. T. (1990a). J chain disease: A novel form of plasma cell dyscrasia. Am. J. Med. 88:411–416.PubMedCrossRefGoogle Scholar
  79. Mestecky, J., Moro, I., Kerr, M. A., and Woof, J. M. (2005). Mucosal immunoglobulins. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 153–181.Google Scholar
  80. Mestecky, J., Preud’homme, J.-L., Crago, S. S., Mihaesco, E., Prchal, J. T., and Okos, A. J. (1980). Presence of J chain in human lymphoid cells. Clin. Exp. Immunol. 39:371–385.PubMedGoogle Scholar
  81. Mestecky, J., and Russell, M. W. (1986). IgA Subclasses. Monogr. Allergy 19:277–301.PubMedGoogle Scholar
  82. Mestecky, J., Waldo, F. B., Britt, W. J., Julian, B. A., Tomana, M., van den Wall Bake, A. W. L., Russell, M. W., Galla, J. H., Moldoveanu, Z., and Jackson, S. (1990b). Exogenous antigens deposited in the glomeruli of patients with IgA nephropathy. In: Sakai, H., Sakai, and Nomoto, Y. (eds.), Pathogenesis of IgA Nephropathy. Harcourt Brace Jovanovich, Tokyo, pp. 247–257.Google Scholar
  83. Mitsiades, C. S., Mitsiades, N., Munshi, N. C., and Anderson, K. C. (2004). Focus on multiple myeloma. Cancer Cell 6:439–444.PubMedCrossRefGoogle Scholar
  84. Mohammadi, J., Hammarström, L., and Aghamohammadi, A. (2007). Induction of CVID. Case reports and a review of the literature. Iran J. Allergy Asthma Immunol. submitted.Google Scholar
  85. Monteiro, R. C., Moura, I. C., Launay, P., Tsuge, T., Haddad, E., Benhamou, M., Cooper, M. D., and Arcos-Fajardo, M. (2002). Pathogenic significance of IgA receptor interactions in IgA nephropathy. Trends Mol. Med. 8:464–468.PubMedCrossRefGoogle Scholar
  86. Moura, I. C., Centelles, M. N., Arcos-Fajardo, M., Malheiros, D. M., Collawn, J. F., Cooper, M. D., and Monteiro, R. C. (2001). Identification of the transferrin receptor as a novel immunoglobulin (Ig) A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J. Exp. Med. 194:417–425.PubMedCrossRefGoogle Scholar
  87. Muller, F., Aukrust, P., Nilssen, D. E., and Frøland, S. S. (1995). Reduced serum level of transforming growth factor-beta in patients with IgA deficiency. Clin. Immunol. Immunopathol. 76:203–208.PubMedCrossRefGoogle Scholar
  88. Novak, J., Julian, B. A., Tomana, M., and Mestecky, J. (2001). Progress in molecular and genetic studies of IgA nephropathy. J. Clin. Immunol. 21:310–327.PubMedCrossRefGoogle Scholar
  89. Novak, J., Tomana, M., Matousovic, K., Brown, R., Hall, S., Novak, L., Julian, B. A., Wyatt, R. J., and Mestecky, J. (2005). IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 67:504–513.PubMedCrossRefGoogle Scholar
  90. Novak, J., Vu, H. L., Novak, L., Julian, B. A., Mestecky, J., and Tomana, M. (2002). Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int. 62:465–475.PubMedCrossRefGoogle Scholar
  91. Oen, K., Petty, R. E., and Schroeder, M. L. (1982). Immunoglobulin A deficiency: Genetic studies. Tissue Antigens 19:174–182.PubMedCrossRefGoogle Scholar
  92. Olerup, O., Smith, C. I., and Hammarström, L. (1990). Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 347:289–290.PubMedCrossRefGoogle Scholar
  93. Olerup, O., Smith, C. I., and Hammarström, L. (1991). Is selective IgA deficiency associated with central HLA genes or alleles of the DR-DQ region? Immunol. Today 12:134–136.PubMedCrossRefGoogle Scholar
  94. Oxelius, V. A., Laurell, A. B., Lindquist, B., Golebiowska, H., Axelsson, U., Björkander, J., and Hanson, L. Å. (1981). IgG subclasses in selective IgA deficiency: importance of IgG2-IgA deficiency. N. Engl. J. Med. 304:1476–1477.PubMedCrossRefGoogle Scholar
  95. Ozawa, N., Shimizu, M., Imai, M., Miyakawa, Y., and Mayumi, M. (1986). Selective absence of immunoglobulin A1 or A2 among blood donors and hospital patients. Transfusion 26:73–76.PubMedCrossRefGoogle Scholar
  96. Pai, M. K., Davison, M., Bedritis, I., and Zipursky, A. (1974). Selective IgA deficiency in Rh-negative women. Vox Sang. 27:87–91.PubMedCrossRefGoogle Scholar
  97. Pan-Hammarström, Q., Du, L., Björkander, J., Cunningham-Rundles, C., Nelson, D. L., Salzer, U., Offer, S., Behrens, T. W., Grimbacher, B., and Hammarström, L. (2007). Mutations in TNFRSF13B encoding TACI and selective IgA deficiency. Nat. Genet. 39:429–430.PubMedCrossRefGoogle Scholar
  98. Peppard, J. V., Kaetzel, C. S., and Russell, M. W. (2005). Phylogeny and comparative physiology of IgA. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 195–210.Google Scholar
  99. Pereira, L. F., Sapina, A. M., Arroyo, J., Vinuelas, J., Bardaji, R. M., and Prieto, L. (1997). Prevalence of selective IgA deficiency in Spain: More than we thought. Blood 90:893.PubMedGoogle Scholar
  100. Petty, R. E., Sherry, D. D., and Johannson, J. (1985). Anti-IgA antibodies in pregnancy. N. Engl. J. Med. 313:1620–1625.PubMedCrossRefGoogle Scholar
  101. Potter, M. (1972). Immunoglobulin-producing tumors and myeloma proteins of mice. Physiol. Rev. 52:631–719.PubMedGoogle Scholar
  102. Radl, J., Schuit, H. R. E., Mestecky, J., and Hijmans, W. (1974). The origin of monomeric and polymeric forms of IgA in man. Adv. Exp. Med. Biol. 45:57–65.PubMedGoogle Scholar
  103. Rambaud, J.-C., Brouet, J.-C., and Seligmann, M. (1994). Alpha chain disease and related lymphoproliferative disorders. In: Ogra, P. L., Mestecky, J., Lamm, M. E., Strober, W., McGhee, J. R., and Bienenstock, J. (eds.), Handbook of Mucosal Immunology. Academic Press, New York, pp. 425–433.Google Scholar
  104. Renegar, K. B., Jackson, G. D., and Mestecky, J. (1998). In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J. Immunol. 160:1219–1223.PubMedGoogle Scholar
  105. Rockey, J. H., Hanson, L. Å., Heremans, J. F., and Kunkel, H. G. (1964). Beta-2A aglobulinemia in two healthy men. J. Lab. Clin. Med. 63:205–212.PubMedGoogle Scholar
  106. Ropars, C., Muller, A., Paint, N., Beige, D., and Avenard, G. (1982). Large scale detection of IgA deficient blood donors. J. Immunol. Methods 54:183–189.PubMedCrossRefGoogle Scholar
  107. Russell, M. W., and Kilian, M. (2005). Biological activities of IgA. In: Mestecky, J., Bienenstock, J., Lamm, M. E., Mayer, L., McGhee, J. R., and Strober, W. (eds.), Mucosal Immunology, 3rd. ed., Elsevier/Academic Press, Amsterdam, pp. 267–289.Google Scholar
  108. Russell, M. W., Lue, C., van den Wall Bake, A. W. L., Moldoveanu, Z., and Mestecky, J. (1992). Molecular heterogeneity of human IgA antibodies during an immune response. Clin. Exp. Immunol. 87:1–6.PubMedCrossRefGoogle Scholar
  109. Russell, M. W., Mestecky, J., Julian, B. A., and Galla, J. H. (1986). IgA-associated renal diseases. Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli. J. Clin. Immunol. 6:74–86.PubMedCrossRefGoogle Scholar
  110. Savilahti, E., Klemola, T., Carlsson, B., Mellander, L., Stenvik, M., and Hovi, T. (1988). Inadequacy of mucosal IgM antibodies in selective IgA deficiency: Excretion of attenuated polio viruses is prolonged. J. Clin. Immunol. 8:89–94.PubMedCrossRefGoogle Scholar
  111. Schaffer, A. A., Pfannstiel, J., Webster, A. D., Plebani, A., Hammarström, L., and Grimbacher, B. (2006). Analysis of families with common variable immunodeficiency (CVID) and IgA deficiency suggests linkage of CVID to chromosome 16q. Hum. Genetics 118:725–729.CrossRefGoogle Scholar
  112. Schroeder, H. W., Jr., Schroeder, H. W., 3rd, and Sheikh, S. M. (2004). The complex genetics of common variable immunodeficiency. J. Investig. Med. 52:90–103.PubMedGoogle Scholar
  113. Smith, A. C., and Feehally, J. (2003). New insights into the pathogenesis of IgA ephropathy. Pathogenesis of IgA nephropathy. Springer Semin. Immunopathol. 24:477–493.PubMedCrossRefGoogle Scholar
  114. Smith, C. I., Moller, G., Severinson, E., and Hammarström, L. (1990). Frequencies of interleukin-5 mRNA-producing cells in healthy individuals and in immunoglobulin-deficient patients, measured by in situ hybridization. Clin. Exp. Immunol. 81:417–422.PubMedCrossRefGoogle Scholar
  115. Socken, D. J., Simms, E. S., Nagy, B. R., Fisher, M. M., and Underdown, B. J. (1981). Secretory component-dependent hepatic transport of IgA antibody-antigen complexes. J. Immunol. 127:316–319.PubMedGoogle Scholar
  116. Stockert, R. J. (1995). The asialoglycoprotein receptor: Relationships between structure, function, and expression. Physiol. Rev. 75:591–609.PubMedGoogle Scholar
  117. Stockert, R. J., Kressner, M. S., Collins, J. C., Sternlieb, I., and Morell, A. G. (1982). IgA interaction with the asialoglycoprotein receptor. Proc. Natl. Acad. Sci. U.S.A. 79:6229–6231.PubMedCrossRefGoogle Scholar
  118. Strothman, R. A., Sedestrom, L. M., Ball, M. J., and Chen, S. N. (1989). HLA association of anti-IgA antibody production. Tissue Antigens 34:141–144.PubMedCrossRefGoogle Scholar
  119. Tjellström, B., Stenhammar, L., Eriksson, S., and Magnusson, K. E. (1993). Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet 341:701–702.PubMedCrossRefGoogle Scholar
  120. Tomana, M., Matousovic, K., Julian, B. A., Radl, J., Konecny, K., and Mestecky, J. (1997). Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 52:509–516.PubMedCrossRefGoogle Scholar
  121. Tomana, M., Novak, J., Julian, B. A., Matousovic, K., Konecny, K., and Mestecky, J. (1999). Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104:73–81.PubMedCrossRefGoogle Scholar
  122. Ulfarsson, J., Gudmundsson, S., Birgisdottir, B., Kjeld, J. M., and Jensson, O. (1982). Selective serum IgA deficiency in Icelanders. Frequency, family studies and Ig levels. Acta Med. Scand. 211:481–487.PubMedGoogle Scholar
  123. Vorechovsky, I., Zetterquist, H., Paganelli, R., Koskinen, S., Webster, A. D. B., Björkander, J., Smith, C. I. E., and Hammarström, L. (1995). Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin. Immunol. Immunopathol. 77:214–218.CrossRefGoogle Scholar
  124. Vyas, G. N., Perkins, H. A., Yang, Y. M., and Basantani, G. K. (1975). Healthy blood donors with selective absence of immunoglobulin A: Prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J. Lab. Clin. Med. 85:838–842.PubMedGoogle Scholar
  125. Waga, I., Yamamoto, J., Sasai, H., Munger, W. E., Hogan, S. L., Preston, G. A., Sun, H. W., Jennette, J. C., Falk, R. J., and Alcorta, D. A. (2003). Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy. Kidney Int. 64:1253–1264.PubMedCrossRefGoogle Scholar
  126. Warrington, R. J., Rutherford, W. J., Sauder, P. J., and Bees, W. C. (1982). Homologous antibody to human immunoglobulin (Ig)-A suppresses in vitro mitogen-induced IgA synthesis. Clin. Immunol. Immunopathol. 23:698–704.PubMedCrossRefGoogle Scholar
  127. Wilton, A. N., Cobain, T. J., and Dawkins, R. L. (1985). Family studies of IgA deficiency. Immunogenetics 21:333–342.PubMedCrossRefGoogle Scholar
  128. Yadav, M., and Lyngkaran, N. (1979). Low incidence of selective IgA deficiency in normal Malaysians. Med. J. Malaysia 34:145–148.PubMedGoogle Scholar
  129. Zhou, W., Pan-Hammarström, Q., Freidin, M., Aarli, J. A., Webster, A. D. B., Olerup, O., and Hammarström, L. (2007). Drug induced immunoglobulin deficiency. Chem. Immunol. in press.Google Scholar
  130. Zickerman, A. M., Allen, A. C., Talwar, V., Olczak, S. A., Brownlee, A., Holland, M., Furness, P. N., Brunskill, N. J., and Feehally, J. (2000). IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am. J. Kidney Dis. 36:E19.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Jiri Mestecky
    • 1
  • Lennart Hammarström
    • 2
  1. 1.Departments of Microbiology and MedicineUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Department of Clinical ImmunologyHuddinge University Hospital, Karolinska InstituteSweden

Personalised recommendations